Do women taking hormone replacement therapy (HRT) have a higher incidence of breast cancer than women who do not?

Integrative Cancer Therapies

Volumn 2, Issue 3, 2003, Pages 235-237

  Fleming, R M ^a  

^a Camelot Foundation   (United States)

Author keywords

Breast cancer; Breast imaging; Breast enhanced scintigraphy test (BEST); Hormone replacement therapy (HRT)

Indexed keywords

ESTROGEN; PROGESTERONE;

ARTICLE; BREAST CARCINOMA; BREAST CELL; BREAST DISEASE; BREAST ENDOPROSTHESIS; BREAST ENHANCED SCINTIGRAPHY TEST IMAGING; CANCER INCIDENCE; CANCER RISK; CELL ACTIVITY; COMPARATIVE STUDY; CONTROLLED STUDY; EMPIRICISM; FEMALE; FIBROCYSTIC BREAST DISEASE; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MITOCHONDRION; PRIORITY JOURNAL; SCINTIMAMMOGRAPHY; STATISTICAL ANALYSIS;

ADULT; BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; FIBROCYSTIC BREAST DISEASE; HORMONE REPLACEMENT THERAPY; HUMANS; INCIDENCE; MIDDLE AGED; MITOCHONDRIA; PREMENOPAUSE; RADIONUCLIDE IMAGING; RISK ASSESSMENT;

EID: 0141539502     PISSN: 15347354     EISSN: None     Source Type: Journal    
DOI: 10.1177/1534735403256346     Document Type: Article

References (7)

1. Million women study collaborators. Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000. Br J Obstet Gynaecol. 2002;109:1319-1330.
2. Siegelmann-Danieli N, Ron I, Kaufman B, Uzieli B, Karminsky N, Inbar M. Hormone replacement therapy in breast cancer survivors: the Israeli society for clinical oncology and radiotherapy policy letter. Harefuah. 2002;141:994-996.
3. Weis LK, Burkman RT, Cushing-Haugen KL, et al. Hormone replacement therapy regimens and breast cancer risk. Obstet Gynecol. 2002;100:1148-1158.
4. Porch JV, Lee IM, Cook NR, Rexrode KM, Burin JE. Estrogen-progestin replacement therapy and breast cancer risk: the Women's health study (United States). Cancer Causes Control. 2002;13:847-854.
5. Fleming RM. Mitochondrial uptake of sestamibi distinguishes between normal, inflammatory breast changes, pre-cancers and infiltrating breast cancer. Int Cancer Ther. 2002;1:229-237.
6. Fleming RM, Dooley WC. Breast enhanced scintigraphy testing (BEST) distinguishes between normal, inflammatory breast changes and breast cancer. A prospective analysis and comparison with mammography. Int Cancer Ther 2002;1:238-245.
7. Snedecor GW and Cochran WG. Statistical Methods. 6th ed. Ames: The Iowa State University Press; 1967.